Categories

What Stays True for U.S. Health Care Post #Election2024 (1) – Consumers’ Dissatisfaction with Drug Prices

For health care, there are many uncertainties as we reflect, one week after the 2024 U.S. elections, on probably policy and market impacts that we can expect in 2025 and beyond. In today’s Health Populi post, I’ll reflect on the first of several certainties we-know-we-know about U.S. health citizens and key factors shaping the American health ecosystem. In this first of several posts on “What Stays True for U.S. Health Care Post #Election2024,” I’ll focus on U.S. consumer dissatisfaction with drug prices — across political party identification.          Let’s set the context with data from a recently-published

 

Doctors’ Recommendations Are Top Motivators for Consumers Who Buy Digital Health Devices: Trust and Health

Most consumers using digital health devices felt more trust in the technology when coupled with doctors’ office reviews — another lens on the importance of trust-equity between patients and physicians. This insight came out of a report on How Consumers Purchase, Use and Trust Medical Devices based on market research sponsored by Propel Software.             For the study, Propel Software engaged Talker Research to conduct a survey among 2,000 U.S. adults in October 2024 to gauge peoples’ views on digital health tools, buying trends, and trust. Start with the rate of 1 in 4 Americans’ experience

 

Health Care Costs and Access On U.S. Voters’ Minds – Even If “Not on the Ballot” – Ipsos/PhRMA

Today marks eight days before #Election2024 in the U.S. While many political pundits assert that “health care is not on the ballot,” I contend it is on voters’ minds in many ways — related to the economy (the top issue in America), social equity, and even immigration (in terms of the health care workforce). In today’s Health Populi blog, I’m digging into  Access Denied: patients speak out on insurance barriers and the need for policy change, a study conducted by Ipsos on behalf of PhRMA, the Pharmaceutical Research and Manufacturers of America — the pharma industry’s advocacy organization (i.e., lobby

 

The Health Insurance Premium for a Family Averages $25,572 in 2024 – KFF’s Annual Update on Employer-Sponsored Benefits

The premium for employer-sponsored health plans grew by 6-7% between 2023 and 2024, according to the report on Employer Health Benefits 2024 Annual Survey from the Kaiser Family Foundation, KFF’s 26th annual study into U.S. companies’ spending on workers’ health care.                 In 2024 the average annual health insurance premium for family coverage is $25,572, split by 75% covered by the employer (just over $19,000) and 25% borne by the employee ($6,296), shown in the first chart from the report. The nearly $26K family premium is the average across all plan types in the

 

Americans Want More Health Care Issues Baked into the 2024 Elections – Gallup

Beyond women’s health and abortion politics, most Americans are looking for more health care baked into the 2024 Elections, based on a new poll from Gallup in collaboration with West Health.           Two in three U.S. adults thought health care was not receiving enough attention during the 2024 Presidential campaign as of September 2024. This is a majority shared opinion for voters across the three party IDs in the U.S., shown in the first bar graph. The research polled 3,660 U.S. adults in September, about two-thirds before the presidential debate held September 10, and about one-third

 

Americans’ Perspectives on Pharma and Healthcare Industries Are Low and Low-Ish Compared with Most Other Sectors

Only 20% of U.S. adults have a positive view of the pharmaceutical industry, garnering the lowest positive vibes among Americans in Gallup’s latest survey on peoples’ opinions of industries in America. About 1 in 3 Americans feel positively about health care in the U.S., on par with publishing and the electric/gas industries — on the lower end of these findings.             By far, the top-perceived industry in the U.S. is agriculture and farming, taking the first spot with 64% of Americans’ positive views. Restaurants and the computer sector get 52% positives, although Gallup points out

 

1 in 2 U.S. Women (“The Bedrock of Society”) Self-Ration Care – the Latest Deloitte Findings

Women in the U.S. are more likely to avoid care than men in America, Deloitte found in the consulting firm’s latest survey on consumers and health care.             Deloitte coins this phenomenon as a “triple-threat” that women face in the U.S. health care environment, the 3 “threats” being, Affordability, Access, and, Prior experience — that is the health disparity among women who have seen personal mis-diagnosis, bias, or treatment that hasn’t been consistent with current protocols and practices. The data come out of Deloitte’s fielding of the U.S. consumer survey in February and March, 2024.

 

Obesity is a Public Health Epidemic in the U.S. — The Case for GLP-1 Coverage, Affordability and Equity

“If the U.S. were sensible, weight management would be treated as a public health issue,” David Cutler writes in the JAMA Health Forum dated August 15, 2024. Dr. Cutler, distinguished economics professor at Harvard, talks about “the pathology of U.S. health care” citing the example of weight loss medications — in short, the uptake of GLP-1 drugs to address Type 2 diabetes first, and subsequently obesity.          Dr. Cutler notes that the price of these drugs in the U.S. “far exceeds” that of other countries: specifically, 9 times that of the prices in Germany and the Netherlands

 

The New DTC Channel Is…A Vending Machine (From Advil to Plan B)

I’m off to Florence, Italy, soon, where about 10 years ago I happened upon a vending machine sited outside of a pharmacy just a few blocks from the Duomo — the Farmacia Della Condotta. And in that vending machine, accessible at all hours (especially overnight when the pharmacy was closed), were all manners of direct-to-consumer self-care goods….including condoms. What distinguished this from other vending machines that might have channeled condoms at the time was that those tended to be located in men’s rooms in, say, bars — not openly on a city street. You can see the Italian vending machine

 

Where Democrats and Republicans Agree on Health Care Policies – From Medicare and Prescription Drugs to Gun Safety

In a super-divided electorate like the U.S. with about 60 days leading up to the 2024 Elections, we might assume there are no “purple” areas of agreement between the Red (Republicans) and the Blue (Democrats) thinking in PANTONE color politics. Surprisingly, there are many health policies on which Democrats and Republicans concur, as found in a series of YouGov polls conducted in May 2024.                         YouGov fielded the health policies poll in five waves online, each among roughly 1,100 U.S. adults in May 2004. This bar chart summarizes health

 

Women’s Health Outcomes in the U.S.: Spending More, Getting (Way) Less – 4 Charts from The Commonwealth Fund

Women in the U.S. have lower life expectancy, greater risks of heart disease, and more likely to face medical bills and self-rationing due to costs, we learn in the latest look into Health Care for Women: How the U.S. Compares Internationally from The Commonwealth Fund.              The Fund identified four key conclusions in this global study: Mortality, shown in the first chart which illustrates women in the U.S. having the lowest life expectancy of 80 years versus women in other high-income countries; Health status, with women in the U.S. more likely to consume multiple prescription

 

The Cost of GLP-1 Drugs on Payers’ Minds as Nearly 1/3rd of U.S. Consumers Could Become Users

With 70 different clinical trials for GLP-1 drugs in process with the FDA, payers — and other stakeholders in the health care ecosystem — have the semaglutide-SENSE top of mind, based on my ongoing updating of this fast-moving market space.               For overall market context on pace-of-growth in adoption, check out this chart from a JAMA Health Forum research letter on Prescription Fills for Semaglutide Products by Payment Method, published August 2nd. The study was based on the IQVIA National Prescription Audit PayerTrak data which captures 92% of Rx’s filled at retail pharmacies in

 

Older Americans Mostly Receptive to Apps for Health, but Chronically Ill People Could Use a Nudge (and a Payer)

AARP found that 7 in 10 people ages 50+ are “app-receptive” for health and wellness apps in Unlocking Health and Wellness Apps: Experiences of Adults Age 50-Plus, a summary of research conducted with U.S. consumers 50 and over from AARP.           The methodology for this study included only older consumers who were comfortable in downloading apps to smartphones or tablets, and were willing to do so — whom AARP considered the target audience for this research. In addition, the respondents surveyed were also at least interested in trying apps designed for health and wellness, thus dubbed “health

 

Medical Debt, Aflac on Eroding Health Benefits, the CBO’s Uninsured Forecast & Who Pays for Rising Health Care Prices: A Health Consumer Financial Update

On June 11, Rohit Chopra, the Director of the Consumer Financial Protection Bureau (CFPB) announced the agency’s vision to ban Americans’ medical debt from credit reports. He called out that, “In recent years, however, medical bills became the most common collection item on credit reports. Research from the Consumer Financial Protection Bureau in 2022 showed that medical collections tradelines appeared on 43 million credit reports, and that 58 percent of bills that were in collections and on people’s credit records were medical bills.” Chopra further explained that medical debt on a consumer credit report was quite different than other kinds

 

Most Americans Follow an Eating Pattern in Search of Energy, Protein, and Well-Being – With Growing Financial Stress: A Food as Medicine Update

Most Americans follow some kind of eating regime, seeking energy, more protein, and healthy aging, according to the annual 2024 Food & Health Survey published this week by the International Food Information Council (IFIC). But a person’s household finances play a direct role in their ability to balance healthful food purchases and healthy eating, IFIC learned.              In this 19th annual fielding of this research, IFIC explored 3,000 U.S. consumers’ perspectives on diet and nutrition, trusted sources for food information, and new insights into peoples’ views on the GLP-1 weight-loss drugs and the growing sense

 

The Most Trusted Brands of 2024 Tell Us A Lot About Health Consumers

From bandages to home hygiene, OTC pain meds and DIY home projects, Morning Consult’s look into the most-trusted brands of 2024 give us insights into health consumers. I’ve been tracking this study since before the public health crisis of the coronavirus, and it always offers us a practical snapshot of the U.S. consumer’s current ethos on trusted companies helping people risk-manage daily living — and of course, find joy and satisfaction as well. In the top 15, we find self-care for health and well-being in many brands and products: we can call out Band-Aid, Dove, Colgate, Kleenex, and Tylenol. For

 

A 2025 Subaru Forester, a Year at U-New Mexico, or a Health Plan for a Family of Four: the 2024 Milliman Medical Index

Health care costs for an “average” person covered by an employer-sponsored PPO in the U.S. rose 6.7% between 2023 and 2024, according to the 2024 Milliman Medical Index. Milliman also calculated that the largest driver of cost increase in health care, accounting for nearly one-half of medical cost increases, was pharmacy, the cost of prescription drugs, which grew 13% in the year.             The big number this year is $32,066, which is the cost of that employer-sponsored PPO for a family of 4 in 2024. I’ve curated the chart of the MMI statistic for many

 

The Thematic Roadmap for AHIP 2024: What the Health Insurance Conference Will Cover

Health insurance plans make mainstream media news every week, whether coverage deals with the cost of a plan, the cost of out-of-network care, prior authorizations, or cybersecurity and ransomware attacks, among other front-page issues. This week, AHIP (the acronym for the industry association of America’s Health Insurance Plans) is convening in Las Vegas for its largest annual 2024 meeting. We expect at least 2,400 attendees registered for the meeting, and they’ll not just be representing the health insurance industry itself; folks will attend #AHIP2024 from other industry segments including pharmaceuticals, technology, hospitals and health systems, and the investment and financial services

 

GLP-1s’ direct and indirect impacts on health care and consumer goods – Jane speaks with Bloomberg BNN

Today, I spoke live with Paul Bagnell, news anchor with Bloomberg BNN, on the topic of the GLP-1 agonists and their impact on health care, industries beyond health and medicine, and consumers. In this post, I’ll share with you some of the plotline for our discussion.               Gallup polled U.S. adults in March to gauge their experience with injectable weight loss drugs, the results published earlier this week. The first chart tells us that 6% of people have used these drugs, and 3% were doing so in March. Consumers using the meds were more

 

Prescriptions Are Up, Health Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA’s 2024 Update

In the past year, the growth of prescription drug utilization and spending has much to do with the use of GLP-1 agonists to treat diabetes and obesity, along with immunology therapy, and lipid meds, along with specialty medicines now accounting for over half of spending — up from 49% in 2018. This update comes from The Use of Medicines in the U.S. 2024 from the IQVIA Institute for Human Data Science. The annual report details trends in health services utilization, the use of prescription drugs, patient financing of those costs, the drivers underpinning the medicines spending, and an outlook to 2028.

 

Inflation, Health, and the American Consumer – “The Devil Wears Kirkland”

The Wall Street Journal reported yesterday that surging hospital prices are helping to keep inflation high.                 Hospital costs rose 7.7% last month, the highest increase in 13 years. This chart from WSJ’s reporting illustrates the >2x change in the CPI for hospitals vs the overall rate of price increases. Hospitals are not alone in price cliffs, with health insurance premiums spiking last year at the fastest rate in a decade, the Labor Statistics data showed. “For patients and their employers, the increases have meant higher health-insurance premiums, as well as limiting wage

 

Leveraging Trust, Showing Humility: How Health Care Organizations Can Serve Consumers – A New Read from McKinsey

Three trends underpin health consumers’ evolving demands for service: spending more but getting less satisfaction and innovation; trusting health care with data but underwhelmed by the use of that personal information; and, growing “shopping” behavior seeking quality, availability, proximity, cost, and options across channels for health care. That’s the current read from McKinsey & Company’s team noting that Consumers rule: Driving healthcare growth with a consumer-led strategy.                 In this health consumer update, McKinsey spoke with three consumer marketing experts from other industries to learn best practices on how best to “be there”

 

Healthcare 2030: Are We Consumers, CEOs, Health Citizens, or Castaways? 4 Scenarios On the Future of Health Care and Who We Are – Part 1

In the past few years, what event or innovation has had the metaphorical impact of hitting you upside the head and disrupted your best-laid plans in health care? A few such forces for me have been the COVID-19 pandemic, the emergence of Chat-GPT, and Russia’s invasion of Ukraine. That’s just three, and to be sure, there are several others that have compelled me to shift my mind-set about what I thought I knew-I-knew for my work with organizations spanning the health care ecosystem. I’m a long-time practitioner of scenario planning, thanks to the early education at the side of Ian

 

Considering Equity and Consumer Impacts of GLP-1 Drugs – A UBS Economist Weighs In

Since the introduction of GLP-1 drugs on the market, their use has split into two categories: for obesity and “recreationally,” according to the Chief Economist with UBS (formerly known as Union Bank of Switzerland). Paul Donovan, said economist, discusses The economics of getting thin in his regularly published comment blog.                   “These different uses have different economic consequences,” Donovan explains: Obese patients who use GLP-1s should become more productive employees, Donovan expects — less subject to prejudice, and less likely to be absent from work. While so-called recreational GLP-1 consumers may experience these

 

Consumers Are So Over Their Paper Chase in Health Care Payments

As we start the month of April 2024 in the U.S., it’s tax season in America with Federal (and other) income taxes due on the 15th of the month. This is also the time my research clock alarm goes off for an important annual report that describes the latest profile of the patient-as-payer in the U.S. ‘Tis the season for J.P. Morgan’s InstaMed team to analyze health care payments data, describing the experiences of consumers, providers and payers in the Trends in Healthcare Payments Fourteenth Annual Report.                   The overall takeaway for

 

Peering Into the Hidden Lives of Patients: a Manifesto from Paytient and Nonfiction

Having health insurance in America is no guarantee of actually receiving health care. It’s a case of having health insurance as “necessary but not sufficient,” as the cost of deductibles, out-of-pocket coinsurance sharing, and delaying care paint the picture of The Hidden Lives of Workplace-Insured Americans.                 That’s the title of a new report that captures the results of a survey conducted in January 2024 among 1,516 employed Americans who received employer-sponsored health insurance. The study was commissioned by Paytient, a health care financial services company, engaging the research firm Nonfiction to conduct the study

 

The Economic Contours of the Change Healthcare Cyber Attack: Taking Stock So Far

On February 22, 2024, I went to a CVS Pharmacy-Inside-Target in my community to fill a prescription for benzonatate 200 mg capsules. I had caught a bad case of the flu the week before, and subsequently suffered a very long tail of a cough. That’s TMI for me to write about in the Health Populi blog, but this story has a current-events twist: the pharmacist could not electronically link with my insurance company to transact my payment. He tried a few work-flows, and ended up using a discount card which in the moment worked for us, and I paid the

 

The Women’s Health Gap Is Especially Wide During Her Working Years – Learning from McKinsey, the World Economic Forum, and AARP in Women’s History Month

There’s a gender-health gap that hits women particularly hard when she is of working age — negatively impacting her own physical and financial health, along with that of the community and nation in which she lives.               March being Women’s History Month, we’ve got a treasure-trove of reports to review — including several focusing on health. I’ll dive into two for this post, to focus in on the women’s health gap that’s especially wide during her working years. The reports cover research from the McKinsey Health Institute collaborating with the World Economic Forum on

 

A Health Consumer Bill of Rights: Assuring Affordability, Access, Autonomy, and Equity

Let’s put “health” back into the U.S. health care system. That’s the mantra coming out of this week’s annual Capitol Conference convened by the National Association of Benefits and Insurance Professionals (NABIP). (FYI you might know of NABIP by its former acronym, NAHU, the National Association of Health Underwriters).         NABIP, whose members represent professionals in the health insurance benefits industry, drafted and adopted a new American Healthcare Consumer Bill of Rights launched at the meeting. While the digital health stakeholder community is convening this week at VIVE in Los Angeles to share innovations in health tech, NABIP

 

Americans Come Together in Worries About Medical Bills, the Cost of Health Care, and Prescription Drug Costs

In the U.S., national news media, Federal statistics, dozens of business leaders  and the Federal Reserve Bank have been talking about an historically positive American economy on a macro level. But among individual residents of the U.S., there is still a negative feeling about the economy in a personal context, revealed in the Kaiser Family Foundation Health Tracking Poll for February 2024.                I’ve selected three figures of data from the KFF’s Poll which make the point that in peoples’ negative feelings about the national economy, their personal feelings about medical costs rank high

 

People With Medical Debt Are Much More Likely to Be in Financial Distress in America

How financially vulnerable are people with medical debt in the U.S.? Significantly more, statistically speaking, we learn from the latest survey data revealed by the National Financial Capabilities Study (NFCS) from the FINRA Foundation. The Kaiser Family Foundation and Peterson Center on Healthcare analyzed the NFCS data through a consumer health care financial lens with a focus on medical debt.          Financial distress takes many forms, the first chart inventories. People with medical debt were most likely lack saving for a “rainy day” fund, feel they’re “just getting by” financially, feel their finances control their life, and

 

The Wellness Market Shaped by Health at Home, Wearable Tech, and Clinical Evidence – Thinking McKinsey and Target

Target announced that the retail chain would grow its aisles of wellness-oriented products by at least 1,000 SKUs. The products will span the store’s large footprint, going beyond health and beauty reaching into fashion, food, home hygiene and fitness. The title of the company’s press release about the program also included the fact that many of the products would be priced as low as $1.99. So financial wellness is also baked into the Target strategy. Globally, the wellness market is valued at a whopping $1.8 trillion according to a report published last week by McKinsey. McKinsey points to five trends

 

Inflation and the cost of health care top U.S. voters’ issues for 2024 elections

The cost of living ranks top in U.S. voters’ minds among many issues Americans are feeling and following in late 2023. A close second in line is affordability of health care, as consumers’ household budgets must make room for paying medical bills — with prescription drug costs also very important as a discussion topic for 2024 Presidential candidates, we learn from the latest KFF Health Tracking Poll published 1 December. The monthly study focused on U.S. voters’ top issues and perspectives on the health system and care approaching the new year of 2024. KFF fielded the study among 1,301 U.S.

 

Healthcare Bills, Affordability, and Self-Rationing Care Will Continue to Challenge U.S. Health Consumers in 2024

Two-thirds of U.S. consumers say they can’t afford to pay their medical bills on-time, based on the 2023 Consumer Survey from Access One, a financial services company focused on healthcare payments.               The report’s title page asks the question, “What options do consumers really want for paying healthcare expenses?” The survey report responds to that question, finding out that nearly one-half of patients have taken some kind of action to reduce their medical expenses. Furthermore, one-third of consumers are not confident they could pay a medical bill of $500 or more. Access One fielded

 

“My Doctor’s Office” Should Accept Wearable Tech Health Data, Most Patients Say

“Do personal health trackers belong in the doctor’s office?” Software Advice wondered. “Yes,” the company’s latest consumer survey found, details of which are discussed in a report published on their website. Unique to this study is the patient sample polled: Software Advice surveyed 876 patients in September 2023 to gauge their perspectives on wearable tech and health. Note that the patient sample was limited to consumers who had seen a health care provider in the past two years and who also owned and used a personal wearable health device such as an Apple Watch or Fitbit. Thus, the responses shared

 

Money and Mental Health in the U.S. – How Difficulty Paying Medical Bills Can Hurt Healing and Well-Being

There is growing evidence on the connection between people’s financial health and their mental health, explored and explained in Understanding the Mental-Financial Health Connection, a study published by the Financial Health Network.             Keep that relationship in mind in the context of a new forecast from Kaiser Family Foundation estimate the 2023 cost for employer-sponsored insurance for a family to reach nearly $24,000 in 2023. That cost is a 7% increase over last year, and is expected to be split with companies covering $17K (about 70%) and employees about $6600 (roughly 30%). KFF heard that

 

Health Care Finance Leaders Look to Cut Costs and Improve Patients’ Financial Experience — Think AI and Venmo

One half-of health care financial leaders plan to invest in technology to cut costs — and most believe that AI has the potential to re-define the entire finance function as they look to Leading the transformation, a study conducted by U.S. Bank among U.S. health finance leaders thinking about emerging technologies.               U.S. Bank fielded a survey among 200 senior health care financial leaders in the U.S., 30% of whom were group CFOs, 20% regional/divisional CFOs, 25% senior managers, and the remaining various flavors of financial managers. All respondents were responsible for at least $100

 

The Healthcare Financial Experience is a Stressful One: the Convergence of our Medical, Retail, and Financial Lives

One in two consumers in the U.S. feel their well-being or healing was negatively impacted by difficulty paying for their medical care. Welcome to the convergence of patients’ health care life with financial and retail lives, we learn from the 2024 Healthcare Financial Experience Study from Cedar.                   And that patient’s positive clinical experience can absolutely reverse the consumer’s perception of the provider, noted by this quote from OSU’s Chief Financial Officer Vincent Tammaro: “We’ve cured you of your ailment, but we’ve harmed you financially.” That’s a form of financial toxicity that

 

Slip Slidin’ Away: the Reputations of Pharma and Healthcare in the U.S. Decline in the Latest Gallup Poll

Oh, how quickly people forget…and slow to forgive. U.S. consumers’ positive views for healthcare, pharma and retail have significantly fallen in just one year, the latest annual Gallup poll of industry rankings in America found as of August 2023. This stat for the pharma industry was the lowest Gallup ever recorded for the sector since 2001.                     I can’t help hearing Paul Simon’s lyrics to Slip Slidin’ Away….”you know the nearer your destination, the more you’re slip slidin’ away” when it comes to health citizens’ perceptions of pharma and the healthcare

 

For Public Health, U.S. Consumers See Opioids, Obesity, and Guns Top 3 Public Health Threats – But Lowering Healthcare & Drug Costs is Job 1 for Government

Americans cite opioids and fentanyl, obesity, and access to guns and firearms as the top three public health challenges this summer of 2023, according to the new Axios/Ipsos American Health Index. As for government priorities dealing with public health, though, U.S. health citizens say the top priority should be lowering the costs of health care and prescription drugs.                 Once again, we see evidence that U.S. consumers bundle their financial wellbeing — in this instance, costs of medical services and medicines — into peoples’ overall sense of health for themselves as individuals and for

 

Cost Trumps Quality of Health Care for Consumers As Their Experience Has Eroded

Patients’ perceptions of health care quality and experience have fallen in the three years since 2020, based on a July 2023 update from The Beryl Institute – Ipsos Px Pulse study.         Start with health care quality, which 58% of U.S. adult patients ranked as “very good or good” in June 2020. The percent of health consumers evaluating their healthcare quality as very good or good fell to 41% of people in June 2023, an erosion of 17 percentage points, shown in the first chart.         Next, consider patients’ ratings on their care experience,

 

GNC Offers “Free Healthcare” — Telehealth, Generic Meds, and Loyalty in the Retail Health Ecosystem

The retail health landscape continues to grow, now with GNC Health offering a new program featuring telehealth and  “curated set” of 40+ generic prescription drugs commonly used in urgent care settings.             The services are available to members of GNC’s new-and-improved loyalty program, GNC PRO Access, which is priced at a fixed fee of $39.99 for one year’s membership. This is available to consumers 18 years of age and older. “As a trusted brand in the health and wellness space, we are thrilled to expand our efforts in helping our customers Live Well by offering

 

There’s a New “O” in Medicine-Town – Welcome OPill to the Front of the Counter

You may not be able to get that ear-worm jingle that goes “O O O Ozempic” out of your musical mind, but I’m happy to tell you there’s a new “O” in town: the Opill. Welcome to the first OTC contraceptive for sale in the USA.                     I wrote about Perrigo’s Opill here in Health Populi in May 2023 as a “signpost on the road to retail health.” It’s official: “The U.S. Food and Drug Administration (FDA) approved Opill®, a progestin-only daily oral contraceptive, for over-the-counter (OTC) use for all ages.

 

Patients-As-Health Care Payers Define What a Digital Front Door Looks Like

In health care, one of the “gifts” inspired by the coronavirus pandemic was the industry’s fast-pivot and adoption of digital health tools — especially telehealth and more generally the so-called “digital front doors” enabling patients to access medical services and personal work-flows for their care. Two years later, Experian provides a look into The State of Patient Access: 2023.                     You may know the name Experian as one of the largest credit rating agencies for consumer finance in the U.S. You may not know that the company has a significant footprint

 

Searching for Health/Care Touchpoints in the 2023 Axios Harris Poll 100

Patagonia, Costco, John Deere, and Trader Joe’s are loved; Twitter, Fox Corp., FTX and The Trump Organization? Not so much. Welcome to 2023 Axios Harris Poll 100 list of companies U.S. consumers rate from excellent in terms of reputation to very poor and, one in particular, “critical.” Exploring the list, we can find insights into consumers’ preferred touchpoints for health, health care, and well-being curated in their daily lives. In this, today’s, Health Populi blog, I consider The 2023 Axios Harris Poll 100 reputation rankings in light of what we learned from the Morning Consult Most Trusted Brands 2023 study

 

The Growing Pet Economy – What It Means for Human Health, Well-Being, and Healthcare Costs

Our pets can be personal and family drivers of health and health care cost savings, according to a new study from  according to a new report from researchers at George Mason University published in their paper, Health Care Cost Savings of Pet Ownership. Reviewing this new paper inspired me to explore the current state of the pet/health market and implications for their human families, my weaving of various stories explored in this Health Populi blog post. Some of the key signposts we’ll cover are: The report on pet ownership driving owners’ health care cost savings A new market analysis of

 

Our Mental and Emotional Health Are Interwoven With What We Eat and Drink – Chewing On the IFIC 2023 Food and Health Survey

As most Americans confess to feeling stressed over the past six months, peoples’ food and beverage choices have been intimately connected with their mental and emotional well-being, we learn from the 2023 Food & Health Survey from the International Food Information Council (IFIC). For this year’s study, IFIC commissioned Greenwald Research to conduct 1,022 interviews with adults between 18 and 80 years of age in April 2023. The research explored consumers’ perspectives on healthy food, the cost of food, approaches to self-care through food consumption, the growing role of social media in the food system, and the influence of sustainability

 

Retail Clinics’ Growing Role in Health Care and Prescription Drug Sales

“It seemed like an odd pairing: shampoo and a throat swab,” observes a new report on the growth of retail health from Definitive Healthcare. But retail clinics are no longer, as the paper explains, “an experiment of a few grocery stores….they’re becoming a major force in the U.S. healthcare system,” asserts the thesis of Retailers in healthcare: A catalyst for provider evolution.                 While the use of emergency departments fell by 1% in the past five years, the use of retail clinics expanded by 70%, Definitive Healthcare calculated. Most retail clinics are owned by

 

Medical Debt: “The Debt of Necessity” – A Current U.S. Picture from the CFPB

On April 11, 2023, three of the largest U.S. consumer credit rating companies — Equifax, Experian and TransUnion — planned to remove medical bill collections that were under $500 from consumers’ credit reports. The Consumer Financial Protection Bureau (CFPB) calculated that these medical bill “erasures” under $500 impacted nearly 23 million consumers and eliminated medical collections totally for 15.6 million people in the U.S. according to CFPB’s recently-published Data Point report. For some context, it’s useful to know that the CFPB was created as part of the Dodd-Frank Wall Street Reform and Consumer Protection Act passed by Congress and signed

 

Getting Health Care at a Retail Pharmacy vs a Retail Store: Consumers May Be Favoring the Pharmacist Versus the Retailer

Not all “retail health” sites are created equal, U.S. consumers seem to be saying in a new study from Wolters Kluwer Health, the company’s second Pharmacy Next: Consumer Care and Cost Trends survey. Specifically, consumers have begun to differentiate between health care delivered at a retail pharmacy versus care offered at a retail store — such as Target or Walmart (both named as sites that offer “health clinics in department stores” in the study press release). While 58% of Americans were likely to visit a local pharmacy as a “first step” when faced with a non-emergency medical situation and 79%

 

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Reviewing the annual 2023 report from the IQVIA Institute for Human Data Science discussing The Use of Medicines in the U.S. is always a detailed, deep, and insightful dive into the state of prescription drugs. It’s a volume speaking volumes on the current picture of prescribed meds, spending and revenues, health care utilization trends, and a forecast looking out to 2027. In my read of this year’s review, I see a flashing light for U.S. health care: “Wake up, public health!” I’ve pulled out a few of the data points that speak to me about population health, prevention and early

 

Women’s Health on Her Own Terms – “She Knows” What She Needs

Despite some improvement in the representation of women by cinema, TV shows, and brands, distortions in media remain that are risks to women receiving appropriate health care. Breaking through taboos of weight, reproductive services, and mental health are the top 3 factors preventing women from getting proper care, according to Health On Her Terms, a research study from WPP and Ogilvy partnering with SeeHer, an organization of collaborations from media, technology, business, education, and other sectors (including over 7,000 brands) focused on the accurate portrayal of women and girls in society. Taglined as “The Marketer’s Hippocratic Oath to Women, the

 

Consumers Expect Every Company to Play a Meaningful Role in “My Health” – New Insights from the 2023 Edelman Trust Barometer

People have expanded their definitions of health in 2023, with mental health supplanting physical health for the top-ranked factor in feeling healthy. Welcome to the Edelman Trust Barometer Special Report: Trust and Health, released this week, with striking findings about how the economic, post-pandemic life, pollution and climate change all feed mis-trust among citizens living in 13 countries — and their eroding trust for health care systems.         While these factors vary by country in terms of relative contribution to citizen trust, note that in the U.S., social polarization plays an outsized role in factors that “make us

 

“Your care, your way:” Learning from the Philips Future Health Index 2023

Consider the key drivers of supply and demand in health care, globally, right now: On the medical delivery supply side, the shortage of staff is a limiting factor to continuing to deliver care based on the usual work-flows and payment models. On the demand side, patients are taking on more demanding roles as consumers with high expectations for service, convenience, and safe care delivered closer to home — or at home. This dynamic informs The Future Health Index 2023 report from Philips, launched this week at HIMSS 2023. This is the eighth annual global FHI report, with detailed country-specific analyses to

 

More Consumers Expect Health/Care Companies to Be Purpose-Ful Versus All Other Industries

If your organization serves health consumers, patients, and caregivers, and you’re asking them to spend money on your services or products, then you’ll do well to be clear on your values and sense of purpose. In the latest Ipsos look into the future of “Purpose,” we find that consumers look most to health and pharmacy companies for shared values, compared with other industries people patronize such as food and grocery, technology and banks.                   To understand where Ipsos is coming from on this aspect of ESG, we’ll start with their territory map

 

The Reputation of Pharma Among U.S. Consumers Is Tied More to Pricing Than to Innovation

In the U.S., price and the cost of medicines is tied to how people feel about the pharma industry, evidenced in the Global Pharma Study 2023 from Caliber. Caliber, a reputation and corporate strategy consultancy, fielded survey research among over 17,000 health consumers including U.S. adults between 18 and 75 years of age as well as health citizens living in Brazil, China, France, Germany, Japan, and the UK.                 Caliber assessed the reputation of 16 industries, globally, finding that pharma ranked 10th among the 16, just below automotive and just above chemicals (and well

 

When Household Economics Blur with Health, Technology and Trust – Health Populi’s 2023 TrendCast

By Jane Sarasohn-Kahn on 22 December 2022 in Anxiety, Behavioral health, Big data and health, Big Tech, Broadband, Business and health, Cardiovascular health, Chronic care, Chronic disease, Connected health, Consumer electronics, Consumer experience, Consumer-directed health, Coronavirus, COVID-19, Cybersecurity, Data analytics and health, Demographics and health, Depression, Design and health, Determinants of health, Diet and health, Digital health, Employee benefits, Employers, Financial health, Financial wellness, Fitness, Food and health, Grocery stores, Health apps, Health at home, Health benefits, Health care industry, Health citizenship, Health Consumers, Health costs, Health disparities, Health Economics, Health ecosystem, Health engagement, Health equity, Health insurance, Health Plans, Health policy, Health politics, Health privacy, Healthcare DIY, Heart disease, Heart health, HIPAA, Home care, Home economics, Home health, Hospitals, Infectious disease, Love and health, Medication adherence, Meditation, Mental health, Mindfulness, Moms and health, Money and health, Out of pocket costs, Patient experience, Personal health finance, Pharmaceutical, Pharmacy, Physicians, Popular culture and health, Prescription drugs, Prevention and wellness, Primary care, Public health, Race and health, Remote health monitoring, Retail health, Risk management, SDoH, Self-care, Shopping and health, Social determinants of health, Specialty drugs, Stress, Telehealth, Telemedicine, Transparency, Trust, User experience UX, Vaccines, Value based health, Virtual health, Vitamins, Wearable tech, Wellbeing, Workplace benefits

People are sick of being sick, the New York Times tells us. “Which virus is it?” the title of the article updating the winter 2022-23 sick-season asked. Entering 2023, U.S. health citizens face physical, financial, and mental health challenges of a syndemic, inflation, and stress – all of which will shape peoples’ demand side for health care and digital technology, and a supply side of providers challenged by tech-enabled organizations with design and data chops. Start with pandemic ennui The universal state of well-being among us mere humans is pandemic ennui: call it languishing (as opposed to flourishing), burnout, or

 

Dollar General & CHPA Collaborate to Bolster Health Consumers’ Literacy and Access for OTC Pain Meds and Self-Care

Health is “made” where we live, work, play, pray, learn….and shop. I spend a lot of time these days in the growing health/care ecosystem where retail health is broadening to address social determinants and drivers of health – namely food, transportation, broadband access, education, environment, and financial wellness – all opportunities for self-care and health engagement. For many years, I have followed the activities of CHPA, the Consumer Healthcare Products Association, and have participated in some of their conferences. Their recent announcement of a collaboration with Dollar General speaks to the growing role of self-care for all people.    

 

Dr. Santa Intends to Deliver Consumer Health-Tech for the 2022 Holidays

Even as consumers’ confess a tighter spending economy for 2022 holiday shopping, peoples’ intent to buy wearable tech for health and fitness and other wellness devices appear on gifting lists in the U.S., according to the 29th Annual Consumer Technology Holiday Purchase Patterns report from the Consumer Technology Association (CTA).             In general, technology will be a top-selling category for 2022 holiday gift-giving, somewhat tempered by inflation and the increased cost of living that challenge household budgets in the fourth quarter of 2022. Tech spending will be down about 6% in 2022 according to CTA’s

 

Health in the 2022 U.S. Midterm Elections – Women, Prescription Drugs, and Who Shows Up to Vote

On Tuesday November 8, 2022, health and medical issues will be on many U.S. voters’ minds as they enter voting booths to select representatives for the House and the Senate, along with some states’ ballots addressing specific healthcare issues. Health policy experts from Manatt, Phelps & Phillips, AARP, and the United States of Care recently shared perspectives on the health care issues on voters’ and policy makers’ minds for the 2022 midterm elections. This post synthesizes their analyses as we lead up to what will be a pivotal election for Americans’ public health, individual well-being, and access to care.  

 

The Patient as Prescription Drug Payer – The GoodRx Playbook

Patients have more financial skin-in-their-healthcare-games facing high-deductibles and direct out-of-pocket costs for medical bills…including prescription drugs. I collaborated with GoodRx on a “yellow paper” discussing The Health Consumers as Payer, with implications and calls-to-action for pharma and life science companies. You can download the paper at this link.               The report is intended to be a playbook for understanding patients’ growing role as consumers and health care payers, providing insights into peoples’ home economic mindsets and how these impact a patient’s adherence to medication based on cost and perceived value. With inflation facing household

 

Health Care Costs Are a Driver of Health Across All of America – Especially for Women

Three in four people in America grade health care costs a #fail, at grade “D” or lower. This is true across all income categories, from those earning under $24,000 a year to the well-off raking in $180K or more, we learn in Gallup’s poll conducted with West Health, finding that Majorities of people rank cost and equity of U.S. healthcare negatively. Entering the fourth quarter of 2022, several studies were published in the past week which reinforce the reality that Americans are facing high health care costs, preventing many from seeking necessary medical services, and hitting under-served health citizens even harder

 

Remember the Social Determinants of Health When Prescribing Drugs

Thinking about the social determinants of prescription drugs, how people take medicines in real life in my latest post in Medecision’s Liberate Health blog.           I had one of those special lightbulb moments when listening to Mauricio Gonzalez-Arias, M.D. of NYC Health + Hospitals and Suvida Healthcare discussing medication adherence and what prevents us from taking our meds as prescribed. His discussion on social determinants’ role in shaping our relationship with prescriptions was powerful, and the jumping off point for this essay.           Medication adherence is a challenge that fiscally costs the

 

The Patient As the Payer: Self-Pay, Bad Debt, and the Erosion of Hospital Finances

“The odds are against hospitals collecting patient balances greater than $7,500,” the report analyzing Hospital collection rates for self-pay patient accounts from Crowe concludes.       Crowe benchmarked data from 1,600 hospitals and over 100,00 physicians in the U.S. to reveal trends on health care providers’ ability to collect patient service revenue. And bad debt — write-offs that come out of uncollected patient bill balances after “significant collection efforts” by hospitals and doctors — is challenging their already-thin or negative financial margins.           The first chart quantifies that bad debt attributable to patients’ self-pay payments

 

Gallup Reveals Americans’ Views on Industry Are the Lowest Since 2008 – Implications for Healthcare and Pharma

Americans’ positive views of 25 industries in the U.S. have declined in the past year. In their latest look into consumers’ views on business in America, Gallup found that peoples’ ratings on business fell to their lowest ratings overall since 2008.           Peoples’ highest ratings of industry in American occurred in 2017 when nearly 50% of people gave business a very or somewhat positive grade. The year-on-year decline from 2021 find oil and gas at the lowest level of positivity, advertising/PR, legal, the Federal government, and pharma at the bottom of the ratings.      

 

Americans Rationing Healthcare in the Inflationary Era; Out-of-Pocket Expenses Are the Concern

Nearly 100 million people in the U.S. cut back on healthcare due to costs in the first half of 2022, according to the latest poll on health care costs form Gallup and West Health, gauging Americans’ financial health in June 2022. That’s the month when inflation in the U.S. reached 9.1%, a 40-year high.             Among Americans’ cuts to household spending was the most common medical self-rationing behavior, delaying or avoiding  care or purchasing prescription drugs, the survey found. Nearly 4 in 5 people in the U.S. had delayed care or prescription meds between January